Busulfan and Cyclophosphamide Followed By Allogeneic Hematopoietic Cell Transplantation In Patients With Hematological Malignancies
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Busulfan (Primary) ; Cyclophosphamide (Primary) ; Allogeneic stem cell therapy; Antithymocyte globulin; Ciclosporin; Ciclosporin; Mycophenolate mofetil
- Indications Haematological malignancies
- Focus Therapeutic Use
- 13 Apr 2021 Biomarkers information updated
- 12 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Nov 2012 Planned initiation date changed from 1 Oct 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.